DSM Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-374,203
| Closed | -$154M | – | 54 |
|
|
2019
Q1 | $154M | Buy |
374,203
+2,823
| +0.8% | +$1.16M | 2.27% | 18 |
|
|
2018
Q4 | $139M | Buy |
371,380
+50,410
| +16% | +$18.5M | 2.39% | 18 |
|
|
2018
Q3 | $130M | Buy |
320,970
+83,276
| +35% | +$31.7M | 1.93% | 20 |
|
|
2018
Q2 | $82M | Sell |
237,694
-47,692
| -17% | -$14.9M | 1.25% | 25 |
|
|
2018
Q1 | $98.3M | Sell |
285,386
-849,954
| -75% | -$296M | 1.36% | 24 |
|
|
2017
Q4 | $427M | Buy |
1,135,340
+73,889
| +7% | +$29.9M | 5.94% | 4 |
|
|
2017
Q3 | $475M | Sell |
1,061,451
-21,642
| -2% | -$10.3M | 6.73% | 3 |
|
|
2017
Q2 | $532M | Buy |
1,083,093
+474,050
| +78% | +$207M | 7.89% | 3 |
|
|
2017
Q1 | $236M | Buy |
609,043
+258,212
| +74% | +$95.7M | 3.85% | 10 |
|
|
2016
Q4 | $129M | Buy |
350,831
+123,883
| +55% | +$47.1M | 2.23% | 21 |
|
|
2016
Q3 | $91.2M | Buy |
226,948
+51,333
| +29% | +$20.6M | 1.47% | 28 |
|
|
2016
Q2 | $61.3M | Sell |
175,615
-8,328
| -5% | -$3.21M | 1.06% | 30 |
|
|
2016
Q1 | $66.3M | Buy |
183,943
+3,310
| +2% | +$1.36M | 1.09% | 31 |
|
|
2015
Q4 | $98.1M | Buy |
180,633
+22,673
| +14% | +$12.3M | 1.54% | 29 |
|
|
2015
Q3 | $73.5M | Sell |
157,960
-101,859
| -39% | -$54.7M | 1.37% | 30 |
|
|
2015
Q2 | $133M | Sell |
259,819
-195,907
| -43% | -$95.6M | 2.26% | 25 |
|
|
2015
Q1 | $206M | Sell |
455,726
-61,213
| -12% | -$25.9M | 3.53% | 11 |
|
|
2014
Q4 | $212M | Sell |
516,939
-3,308
| -0.6% | -$1.3M | 3.91% | 7 |
|
|
2014
Q3 | $188M | Sell |
520,247
-11,683
| -2% | -$3.92M | 3.72% | 8 |
|
|
2014
Q2 | $150M | Buy |
531,930
+48,663
| +10% | +$14.4M | 3.05% | 15 |
|
|
2014
Q1 | $145M | Buy |
483,267
+120,154
| +33% | +$37M | 3.03% | 17 |
|
|
2013
Q4 | $99.9M | Buy |
+363,113
| New | +$104M | 2% | 25 |
|
Other funds holding REGN
